Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| uniQure N.V. | 43,250 | reported | 27 Jan 2017 | tx 4+173,000 |
| Rubius Therapeutics, Inc. | 5,343 | reported | 01 Feb 2022 | tx 11+636,125−60,807 |
| Mural Oncology plc | 0 | reported | 05 Dec 2025 | tx 16+231,449−231,449 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 Dec 2025 | OTHER | Mural Oncology plc | 68,834 | — | |
| 05 Dec 2025 | OTHER | Mural Oncology plc | 54,242 | — | deriv |
| 05 Dec 2025 | OTHER | Mural Oncology plc | 31,200 | — | deriv |
| 05 Dec 2025 | OTHER | Mural Oncology plc | 65,000 | — | deriv |
| 22 Jul 2025 | SALE | Mural Oncology plc | 2,572 | 2.48 USD | |
| 18 Jul 2025 | SALE | Mural Oncology plc | 2,158 | 2.48 USD | |
| 04 Mar 2025 | SALE | Mural Oncology plc | 1,262 | 3.36 USD | |
| 03 Mar 2025 | GRANT_AWARD | Mural Oncology plc | 35,000 | 0.00 USD | |
| 05 Mar 2025 | SALE | Mural Oncology plc | 1,469 | 3.45 USD | |
| 03 Mar 2025 | GRANT_AWARD | Mural Oncology plc | 65,000 | 0.00 USD | deriv |
| 23 Dec 2024 | SALE | Mural Oncology plc | 2,555 | 3.27 USD | |
| 18 Jul 2024 | SALE | Mural Oncology plc | 2,157 | 3.41 USD | |
| 01 Mar 2024 | GRANT_AWARD | Mural Oncology plc | 16,800 | 0.00 USD | |
| 01 Mar 2024 | GRANT_AWARD | Mural Oncology plc | 31,200 | 0.00 USD | deriv |
| 14 Dec 2023 | GRANT_AWARD | Mural Oncology plc | 29,207 | 0.00 USD | |
| 14 Dec 2023 | GRANT_AWARD | Mural Oncology plc | 54,242 | 0.00 USD | deriv |
| 29 Jan 2022 | EXERCISE | Rubius Therapeutics, Inc. | 8,075 | — | |
| 01 Feb 2022 | SALE | Rubius Therapeutics, Inc. | 2,732 | 6.57 USD | |
| 31 Jan 2022 | GRANT_AWARD | Rubius Therapeutics, Inc. | 143,750 | 0.00 USD | deriv |
| 29 Jan 2022 | EXERCISE | Rubius Therapeutics, Inc. | 8,075 | 0.00 USD | deriv |
| 31 Jan 2022 | GRANT_AWARD | Rubius Therapeutics, Inc. | 34,500 | 0.00 USD | deriv |
| 15 Mar 2021 | SALE | Rubius Therapeutics, Inc. | 25,000 | 20.24 USD | |
| 15 Mar 2021 | EXERCISE | Rubius Therapeutics, Inc. | 25,000 | 7.70 USD | |
| 15 Mar 2021 | EXERCISE | Rubius Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 29 Jan 2021 | GRANT_AWARD | Rubius Therapeutics, Inc. | 142,500 | 0.00 USD | deriv |